Bone and Soft Tissue Sarcoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-18
Clinical Trial Update: A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma [Phase 2]
A Phase 2, single-arm trial evaluating fruquintinib plus envafolimab in advanced or unresectable locally advanced bone and soft tissue sarco…